Overview
Updated 14 Jul 2026
Ignacio I. Wistuba is Chair, Department of Translational Pathology, Moffitt Cancer Center. The public record shows 2,842 publications with 106,388 citations (h-index 156), centered on Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers. It also documents 6 NIH-funded awards (1993–2025).
- Most recent indexed publication: 2026 · Cancer immunology research
- Top research focus: Lung Cancer Treatments and Mutations
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 728.
Clinical & industrytrials, payments and federal funding
Not shown. No U.S. clinical registration on file.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
Updated 14 Jul 2026
6 NIH research awards on record, funded 1993–2025 per NIH RePORTER. The latest:
- 05 Tissue Biospecimen and Pathology Resource
University of Tx Md Anderson Can Ctr
FY2025$1,067,922P30CA016672 - ECOG-ACRIN Biospecimen Bank to Support NCTN
Ecog-Acrin Medical Research Foundation
FY2024$3,940,623U24CA196172 - MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
University of Tx Md Anderson Can Ctr
FY2024$1,828,332U24CA224285
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.
Cancer immunology research
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02The 2015 World Health Organization Classification of Lung Tumors4,549 citations2015
- 03Somatic mutations affect key pathways in lung adenocarcinoma2,739 citations2008
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Surgical pathology training at Catholic University of Chile
Santiago; postgraduate diploma in oncologic diagnosis and postgraduate certificate in pathological anatomy …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →teamdraft.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- Elected Member
IASLC Board of Directors (Board Member Europe, Any Gender/Any Specialty seat), 2023 election
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ilcn.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
Awards & honorshonors on the public record
- Mary J. Matthews Pathology/Translational Research Award
International Association for the Study of Lung Cancer (IASLC), presented September 23, 2018 at WCLC Toronto …
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Secondary affiliationsappointments beyond the home institution
- Former (through ~May/June 2025): Professor and Chair
Department of Translational Molecular Pathology, Division of Pathology & Laboratory Medicine …
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Former Director (11 years, through 2025)
ECOG-ACRIN Central Biorepository and Pathology Facility (CBPF) at MD Anderson; succeeded by Dr. Scott D. Jewell in this specific directorship following the Moffitt move …
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Co-Investigator
NCI Early Detection Research Network (EDRN), UT MD Anderson site
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →edrn.cancer.gov ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Ignacio-I-Wistuba-38687933
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/ignacio-i-wistuba-98a735377
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/MdWistuba
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/wafike_great-to-meet-dr-ignacio-wistuba-at-md-anderson-activity-7212239171246026752-bFfo
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/MoffittNews/status/1929212477947941008
- X / Twitter
x.com/MoffittNews/status/1953807184963215630
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
- 5,579
- publications
- 233
- h-index
- 24
- trials
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
- 1,905
- publications
- 187
- h-index
- 1
- trial
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
- 2,643
- publications
- 148
- h-index
- 8
- trials